Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elin S Gray

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Ebiomedicine|February 13, 2016
Arterial or Venous: Where Are the Circulating Tumor Cells?Elin S Gray
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
Transcript-Based Detection of Circulating Melanoma CellsMichael Morici, Weitao Lin, Elin S Gray
Cancer Letters|June 11, 2013
Heat stress: a risk factor for skin carcinogenesisLeslie Calapre, Elin S Gray, Mel Ziman
Current Opinion in HIV and AIDS|January 6, 2010
Specificity of the autologous neutralizing antibody responsePenny L Moore, Elin S Gray, Lynn Morris
BMC Cancer|November 16, 2019
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case reportLeslie Calapre, Lydia Warburton, Michael Millward, et al.
Frontiers in Oncology|March 22, 2013
Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoringDragana Klinac, Elin S Gray, Michael Millward, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
Isolation and Quantification of Plasma Circulating Tumor DNA from Melanoma PatientsGabriela Marsavela, Anna Reid, Elin S Gray, et al.
Biochimica Et Biophysica Acta. General Subjects|September 21, 2020
Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini reviewLokeswari P Tangella, Michael E Clark, Elin S Gray
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma CellsAaron B Beasley, Emmanuel Acheampong, Weitao Lin, et al.
Cancers|September 14, 2024
HLA-A01 and HLA-B27 Supertypes, but Not HLA Homozygocity, Correlate with Clinical Outcome among Patients with Non-Small Cell Lung Cancer Treated with Pembrolizumab in Combination with ChemotherapyAfaf Abed, Anna Reid, Ngie Law, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Ebiomedicine|February 13, 2016
Arterial or Venous: Where Are the Circulating Tumor Cells?Elin S Gray
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
Transcript-Based Detection of Circulating Melanoma CellsMichael Morici, Weitao Lin, Elin S Gray
Cancer Letters|June 11, 2013
Heat stress: a risk factor for skin carcinogenesisLeslie Calapre, Elin S Gray, Mel Ziman
Current Opinion in HIV and AIDS|January 6, 2010
Specificity of the autologous neutralizing antibody responsePenny L Moore, Elin S Gray, Lynn Morris
BMC Cancer|November 16, 2019
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case reportLeslie Calapre, Lydia Warburton, Michael Millward, et al.
Frontiers in Oncology|March 22, 2013
Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoringDragana Klinac, Elin S Gray, Michael Millward, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
Isolation and Quantification of Plasma Circulating Tumor DNA from Melanoma PatientsGabriela Marsavela, Anna Reid, Elin S Gray, et al.
Biochimica Et Biophysica Acta. General Subjects|September 21, 2020
Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini reviewLokeswari P Tangella, Michael E Clark, Elin S Gray
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma CellsAaron B Beasley, Emmanuel Acheampong, Weitao Lin, et al.
Cancers|September 14, 2024
HLA-A01 and HLA-B27 Supertypes, but Not HLA Homozygocity, Correlate with Clinical Outcome among Patients with Non-Small Cell Lung Cancer Treated with Pembrolizumab in Combination with ChemotherapyAfaf Abed, Anna Reid, Ngie Law, et al.
Pageof 11